Repeated Transcranial Magnetic Stimulation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Clinical Trial
A legfontosabb adatok
- Ki végzi
- The First Affiliated Hospital of Soochow University
- Hol
- Suzhou (Kína)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 46 fő, tervezett
- Kezdés
- 2024. dec. 1.
- Tervezett befejezés
- 2026. júl. 1.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- rTMS group
- sham device
- A regiszteradat frissítve
- 2026. május 12.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with irritable bowel syndrome where diarrhea is the main problem (IBS-D). It tests magnetic stimulation of the brain (rTMS) against a fake treatment.
- Életkor
- The criteria say 18 to 60 years. The record's age limits say 18 to 70 years.
- Nem
- All sexes can join.
- A betegség stádiuma
- IBS-D by the Rome IV criteria, with moderate to severe symptoms (IBS-SSS score greater than 175 out of 500). Belly pain at least 1 day per week in the last 3 months. More than 25% of stools are loose (Bristol type 6 or 7), fewer than 25% hard (type 1 or 2).
- Korábbi kezelés
- No probiotics, prebiotics, antibiotics (including rifaximin), drugs that speed up the gut, anti-diarrhea drugs, tricyclic antidepressants or immune-suppressing drugs in the 4 wk before screening. People over 50 need a normal colonoscopy within the last 3 years.
A részvétel fő kizáró okai
- Other bowel disease such as inflammatory bowel disease, or past bowel surgery or gallbladder removal
- Helicobacter pylori infection found in the past 2 years, or gluten or lactose intolerance
- Past cancer, or neurological or psychiatric conditions
- Pregnancy, breastfeeding, or giving birth in the last 12 months
- Heart pacemaker, metal allergy, severe fear of needles, or severe diabetes, thyroid, liver, kidney or heart problems
A regiszter feltételei, szó szerint
Mind a 2 feltétel megnézéseKevesebb
Ki vehet részt
- Eligible participants had to be between 18- 60 years of age and fulfill the Rome IV criteria for IBS-D. Specifically, patients must have experienced recurrent abdominal pain at least one day per week in the last three months, with symptom onset at least six months prior to diagnosis, associated with defecation or a change in the frequency or form (appearance) of stool. More than 25% of stool episodes be classified as Bristol Stool Form Scale (BSFS) type 6 or 7, and fewer than 25% as type 1 or 2. In addition, patients were required to exhibit moderate to severe symptoms, defined as an Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS) score greater than 175 (on a 500-point scale). Dietary preferences of all participants included non vegetarian options and participants maintain stable dietary habits for at least one month prior to randomization. Moreover, patients aged over 50 were required to provide documentation of a normal colonoscopy performed within the preceding three years
Ki nem vehet részt
- The exclusion criteria included a completion rate of daily diaries of less than 50% during the screening period, a history of organic gastrointestinal disease, such as inflammatory bowel disease, a history of surgical resection of the GI tract or cholecystectomy, a recent diagnosis of Helicobacter pylori infection within the past 2 years, a history of gluten or lactose intolerance, a history of malignancy, or a history of neurological or psychiatric conditions. Additionally, individuals with severe systemic diseases, including uncontrolled diabetes mellitus, hyperthyroidism, or severe hepatic, renal, or cardiac insufficiency, were excluded. The use of probiotic or prebiotic supplements, antibiotics (including rifaximin), prokinetic or antidiarrheal agents, tricyclic antidepressants, or immunosuppressive therapies was not permitted within 4 wk prior to screening. Prohibited conditions during the study period included pregnancy, lactation, or being within 12 months postpartum. Lastly, participants with severe needle phobia, metal allergies, implanted cardiac pacemakers, or a known allergic diathesis were excluded. All participants provided their voluntary, written, informed consent prior to their inclusion
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 70 év között vagy?
Ez a vizsgálat jelenleg itt érhető el: Kína.
- The First Affiliated Hospital of Soochow UniversitySuzhou, KínaContact: Wu ShuangjieRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
Objectives: This study aims to evaluate the clinical efficacy and safety of repetitive transcranial magnetic stimulation (rTMS) in patients with diarrhea-predominant irritable bowel syndrome (IBS-D), and to explore the potential underlying mechanisms by which rTMS alleviates clinical symptoms in IBS-D patients.
A teljes eredeti leírásKevesebb
Design: This is a clinical trial that uses clinical symptom scales to assess the therapeutic effect of rTMS on IBS-D patients. Meanwhile, gut microbiota and metabolite profiling, as well as the methane-hydrogen breath test, will be applied to investigate the mechanism of action from the perspectives of gut microecology, intestinal motility, and metabolism, so as to provide scientific evidence for the clinical application of rTMS in the treatment of IBS-D.
A vizsgálat 2 csoportja
- repeated transcranial magnetic stimulation groupMár használt kezelés, összehasonlításként
The rTMS group was given 1 Hz/s for 20 minutes for 3 weeks.
Kezelés: rTMS group
- sham repetitive transcranial magnetic stimulation groupSzínlelt kezelés, összehasonlításként
For the sham rTMS group, the coil was placed over the mPFC with the rTMS function disabled, and pre-recorded acoustic artifacts were played to mimic the auditory experience of the rTMS group.
Kezelés: sham device
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Repeated Transcranial Magnetic Stimulation (rTMS) for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Clinical Trial
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Kérdések a feltételekről
- Forrás: NCT07581756: ki vehet részt
- A regiszteradat frissítve
- 2026. május 12.